Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes
Shweta Bhatt, Rohit N. Kulkarni(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Rachael N. Martínez(Joslin Diabetes Center), Hillary A. Keenan(Joslin Diabetes Center), Richard Smith(Salisbury NHS Foundation Trust), Ercument Dirice(Joslin Diabetes Center), Amy J. Wagers(Harvard University), Tomozumi Takatani(Brigham and Women's Hospital), Mogher Khamaisi(Joslin Diabetes Center), Patrick Guye(Emergent Behaviors of Integrated Cellular Systems), Abdelfattah El Ouaamari(New York Medical College), Therese RW Clauss(Pacific Northwest National Laboratory), Chong Wee Liew(University of Illinois Chicago), Jun Shirakawa(Gunma University), Weijun Qian(Pacific Northwest National Laboratory), Bridget K. Wagner(Broad Institute), Ron Weiss(Massachusetts Institute of Technology), Manoj K. Gupta(Brigham and Women's Hospital), Gongxiong Wu(Joslin Diabetes Center), George M. Church(Harvard University), Volker Busskamp(Médecins Sans Frontières), Marina A. Gritsenko(Pacific Northwest National Laboratory), Ivan Valdez(Brigham and Women's Hospital)
Cited by 46
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
Highly efficient Cas9-mediated transcriptional programming
|Nature Methods|2015|1.6k
Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome
|Science|2005|1.4k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k